Photodynamic therapy for peri‑implant diseases: realistic benefits for your chair

Adjunctive photodynamic therapy can give small, short‑term improvements in bleeding and pocket depth when added to mechanical debridement — useful as a minimally invasive adjunct but not a replacement for thorough debridement, surgical management of osseous defects, or rigorous maintenance.

A 2026 umbrella review in the Journal of Dentistry summarised 30 systematic reviews of photodynamic therapy (PDT) used alongside non‑surgical mechanical debridement for peri‑implant mucositis and peri‑implantitis. The authors found consistent signals that PDT reduces inflammation and microbial load in the short to medium term, but also concluded that the underlying reviews were heterogeneous and of variable quality, limiting the strength of recommendation. ([eurekamag.com](

If you want numbers to set patient expectations: pooled analyses from recent systematic reviews show small average probing‑depth improvements versus debridement alone (often between about 0.4 mm and 0.8 mm) at early follow‑ups (3–6 months), and a clearer effect on bleeding on probing and inflammatory indices than on hard‑tissue gain. These are clinically modest gains — useful for soft‑tissue control but not evidence of predictable bone re‑osseointegration. ([frontiersin.org](

What this means on Monday morning. Use PDT as an adjunct when your goal is to reduce soft‑tissue inflammation quickly and when a minimally invasive option is preferred: for peri‑implant mucositis, for early peri‑implantitis without deep bony defects, or in patients where systemic antibiotics are undesirable. Do not expect PDT to replace mechanical biofilm disruption, to sterilise a contaminated rough implant surface, or to reliably regenerate lost crestal bone. If radiographs show circumferential bone loss or crater defects, plan for surgical access and decontamination; these situations usually need more than topical photochemistry. ([pmc.ncbi.nlm.nih.gov](

A practical, low‑cost protocol that fits modest clinics. Use PDT only after competent mechanical debridement (ultrasonic and/or hand curettes and air‑polishing where available). Apply the photosensitiser according to manufacturer instructions, allow the incubation time, then deliver light with the correct wavelength and energy dose. Expect to repeat PDT at maintenance visits if inflammation recurs. Keep records (PD, BoP, plaque, photos) and review at 3 months to judge effect. The umbrella review emphasises that protocols differ widely between studies, so standardisation at your clinic will help you evaluate whether it helps your patients. ([eurekamag.com](

Which patients are best suited. Prioritise patients with peri‑implant mucositis, shallow peri‑implant pockets (≤5 mm) without radiographic bone loss, patients with medical reasons to avoid systemic antibiotics, and those willing to attend close supportive peri‑implant therapy. For high‑risk patients (history of periodontitis, uncontrolled diabetes, heavy smokers) PDT can be an adjunct but close maintenance and correction of prosthetic/positioning issues remain the priorities. The recent consensus emphasises that risk control and thorough biofilm removal are the foundations of any successful treatment. ([pmc.ncbi.nlm.nih.gov](

Limitations and honest counselling. Tell patients the likely benefit is modest: a short‑term reduction in bleeding and a small average pocket‑depth improvement. Evidence quality is low to moderate because trials used different photosensitisers, light sources, dosages and follow‑up times; long‑term benefits and effects on bone are unproven. Use PDT as a tool in a broader treatment plan, not as a stand‑alone cure. ([eurekamag.com](